← Back
$PHAT All transactions

Phathom Pharmaceuticals, Inc.

A

$ Value

$0

Shares

13,000

Price

$0

Filed

Mar 3

Insider

Name

Breedlove Robert Charles

Title

Principal Accounting Officer

CIK

0002066645

Roles

Officer

Transaction Details

Transaction Date

2026-02-27

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

60,068

Footnotes

Represents restricted stock units ("RSUs") granted on February 27, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of February 27, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. | Represents shares issued upon vesting of performance stock units granted to the reporting person on February 27, 2025 based on the achievement of performance criteria determined to be satisfied on February 27, 2026. | Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation. | Represents shares underlying RSUs that were surrendered by the reporting person to the Issuer upon vesting of such RSU in satisfaction of the Issuer's tax withholding obligation.

Filing Info

Accession No.

0001193125-26-088730

Form Type

4

Issuer CIK

0001783183

Breedlove Robert Charles's History

Date Ticker Type Value
2026-02-27 PHAT A $0
2026-02-27 PHAT A $0
2026-02-27 PHAT F $12K
2026-02-27 PHAT F $5K
2026-01-21 PHAT F $11K
2025-12-18 PHAT F $4K
2025-11-03 PHAT $7K
2025-09-05 PHAT $6K
2025-07-16 PHAT $14K
2025-05-19 PHAT A $0

Other Insiders at PHAT (90d)

Insider Bought Sold Last
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
2026-02-10
Basta Steven L
President and CEO
2026-02-10
Parikh Asit 2026-03-10
Breedlove Robert Charles
Principal Accounting Officer
2026-02-27